GL1X · GenesisL1 explorer

UniProt P03303

Genome polyprotein (P03303)

Genome polyprotein (UniProt P03303), EC 2.7.7.48, 3.4.22.28: 88 experimental structures on GenesisL1, 26 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P03303
Protein
Genome polyprotein
EC
2.7.7.48, 3.4.22.28, 3.4.22.29, 3.6.1.15
Experimental structures
88
Predicted models
0
Pockets
26 · 2 records with a druggable one

Structures

88 records of P03303 in the MolNFT archive: 88 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1D3ICryo-EM structure of human rhinovirus 14 (HRV14) complexed with a two-domain fragment of its…electron microscopy1, 2, 3, 4——
1D3ICryo-EM structure of human rhinovirus 14 (HRV14) complexed with a two- domain fragment of its…electron microscopy1, 2, 3, 4——
1HRIStructure determination of antiviral compound sch 38057 complexed with human rhinovirus 14x-ray diffraction1, 2, 3, 4——
1HRIStructure determination of antiviral compound sch 38057 complexed with human rhinovirus 14x-ray diffraction1, 2, 3, 4——
1HRVHRV14/SDZ 35-682 complexx-ray diffraction1, 2, 3, 4——
1HRVHRV14/SDZ 35-682 complexx-ray diffraction1, 2, 3, 4——
1K5MCrystal Structure of a Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 V3 Loop…x-ray diffractionA, B, C, D——
1K5MCrystal structure of a human rhinovirus type 14:HUMAN immunodeficiency virus type 1 V3 loop…x-ray diffractionA, B, C, D——
1NA1The structure of HRV14 when complexed with Pleconarilx-ray diffractionA, B, C, D——
1NA1The structure of HRV14 when complexed with pleconarilx-ray diffractionA, B, C, D——
1NCQThe structure of HRV14 when complexed with pleconaril, an antiviral compoundx-ray diffractionA, B, C, D——
1NCQThe structure of HRV14 when complexed with pleconaril, an antiviral compoundx-ray diffractionA, B, C, D——
1R08Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
1R08Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
1R09Human rhinovirus 14 complexed with antiviral compound R 61837x-ray diffraction1, 2, 3, 4——
1R09Human rhinovirus 14 complexed with antiviral compound R 61837x-ray diffraction1, 2, 3, 4——
1RMUThree-dimensional structures of drug-resistant mutants of human rhinovirus 14x-ray diffraction1, 2, 3, 4——
1RMUThree-dimensional structures of drug-resistant mutants of human rhinovirus 14x-ray diffraction1, 2, 3, 4——
1RUCRhinovirus 14 mutant N1105S complexed with antiviral compound win 52035x-ray diffraction1, 2, 3, 4——
1RUCRhinovirus 14 mutant N1105S complexed with antiviral compound win 52035x-ray diffraction1, 2, 3, 4——
1RUDRhinovirus 14 mutant N1105S complexed with antiviral compound win 52084x-ray diffraction1, 2, 3, 4——
1RUDRhinovirus 14 mutant N1105S complexed with antiviral compound win 52084x-ray diffraction1, 2, 3, 4——
1RUERhinovirus 14 site directed mutant N1219A complexed with antiviral compound win 52035x-ray diffraction1, 2, 3, 4——
1RUERhinovirus 14 site directed mutant N1219A complexed with antiviral compound win 52035x-ray diffraction1, 2, 3, 4——
1RUFRhinovirus 14 (HRV14) (mutant with asn 1 219 replaced by ala (N219A in chain 1)x-ray diffraction1, 2, 3, 4——
1RUFRhinovirus 14 (HRV14) (mutant with asn 1 219 replaced by ala (N219A in chain 1)x-ray diffraction1, 2, 3, 4——
1RUGRhinovirus 14 mutant N1219S complexed with antiviral compound win 52035x-ray diffraction1, 2, 3, 4——
1RUGRhinovirus 14 mutant N1219S complexed with antiviral compound win 52035x-ray diffraction1, 2, 3, 4——
1RUHRhinovirus 14 mutant N1219S complexed with antiviral compound win 52084x-ray diffraction1, 2, 3, 4——
1RUHRhinovirus 14 mutant N1219S complexed with antiviral compound win 52084x-ray diffraction1, 2, 3, 4——
1RUIRhinovirus 14 mutant S1223G complexed with antiviral compound win 52084x-ray diffraction1, 2, 3, 4——
1RUIRhinovirus 14 mutant S1223G complexed with antiviral compound win 52084x-ray diffraction1, 2, 3, 4——
1RUJRhinovirus 14 mutant with ser 1 223 replaced by gly (S1223G)x-ray diffraction1, 2, 3, 4——
1RUJRhinovirus 14 mutant with ser 1 223 replaced by gly (S1223G)x-ray diffraction1, 2, 3, 4——
1RVFFab complexed with intact human rhinovirusx-ray diffraction1, 2, 3, 4——
1RVFFab complexed with intact human rhinovirusx-ray diffraction1, 2, 3, 4——
1VRHHRV14/SDZ 880-061 complexx-ray diffraction1, 2, 3, 4——
1VRHHRV14/SDZ 880-061 complexx-ray diffraction1, 2, 3, 4——
1XR5Crystal Structure of the RNA-dependent RNA Polymerase 3D from human rhinovirus serotype 14x-ray diffractionA——
1XR5Crystal structure of the RNA-dependent RNA polymerase 3D from human rhinovirus serotype 14x-ray diffractionA——
2B0FNMR Structure of the Human Rhinovirus 3C Protease (serotype 14) with covalently bound…solution nmrA——
2B0FNMR structure of the human rhinovirus 3C protease (serotype 14) with covalently bound…solution nmrA——
2HWBA comparison of the anti-rhinoviral drug binding pocket in hrv14 and hrv1ax-ray diffraction1, 2, 3, 4——
2HWBA comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1Ax-ray diffraction1, 2, 3, 4——
2HWCA comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1Ax-ray diffraction1, 2, 3, 4——
2HWCA comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1Ax-ray diffraction1, 2, 3, 4——
2IN2NMR Structure of the Apo Human Rhinovirus 3C Protease (serotype 14)solution nmrA——
2IN2NMR structure of the apo human rhinovirus 3C protease (serotype 14)solution nmrA——
2R04Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2R04Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2R06Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2R06Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2R07Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2R07Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2RM2Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2RM2Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2RMUThree-dimensional structures of drug-resistant mutants of human rhinovirus 14x-ray diffraction1, 2, 3, 4——
2RMUThree-dimensional structures of drug-resistant mutants of human rhinovirus 14x-ray diffraction1, 2, 3, 4——
2RR1Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——
2RR1Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesx-ray diffraction1, 2, 3, 4——

28 records more on the page itself.

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.